Author

Eleni Andreopolu

Institutions: Weill Cornell Medical Center, Columbia University

Observed institutions: Weill Cornell Medical Center, Columbia University

OpenAlex ID: A5020770384

Abstract GS1-07: Results from a phase III randomized, placebo-controlled clinical trial evaluating adjuvant endocrine therapy +/- 1 year of everolimus in patients with high-risk hormone receptor-positive, HER2-negative breast cancer: SWOG S1207

2023 · Marianna Chavez, Jieling Miao, et al. · Cancer Research · 4

Abstract PO5-25-04: Predictive value of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in patients with triple negative breast cancer treated with pembrolizumab

2024 · Ashley Schreier, Roberta Zappasodi, et al. · Cancer Research

Abstract PO5-08-11: Genetic Landscape of Early Breast Cancer in an Ashkenazi Jewish Cohort

2024 · Laura Munoz Arcos, Eleonora Nicolò, et al. · Cancer Research

Works count: 3

Citation count: 4

H-index: 1

I10-index: